Skip to main content
. 2021 Mar 8;13(5):1157. doi: 10.3390/cancers13051157

Table 2.

Characteristics of exosomes derived from human mesenchymal stem cells (MSCs) and other human immune cells.

Source of Exosomes Markers Characteristic miRNAs Cargo/Pathway Role Reference(s)
MSC-derived exosomes
(BM-MSCs-exo, AD-MSCs-exo, UC-MSCs-exo, and PL-MSCs-exo)
CD9,CD34,CD44,CD63,CD81,CD90, CD105, ALix, TSG101, OCN, OPN, BMP-7, NKG2D ULBPs miR-155, miR-146 P13K/AKT/AKT mTOR, TGF-β/Smad/β-catenin, STAT3/Bcl-2/Beclin1, IL-6, ERK1/2, P38, MAPK Immunosuppressive [129,130,131,132,133]
  1. Mature DEXs

  2. Immature DEXs

CD63, CD81, CD82, αMβ2, MFG-E8 miR-155 Syntenin Gi2α, β-catenin Immunostimulatory [134]
Annexins, CD63, Alix, TSG101, Calnexin and CCR-7 miR-125b-5p, miR-146a, and miR-148 Syntenin Gi2α, β-catenin Immunosuppressive [135]
NKC-derived exosomes
(NK-exo)
CD56 miR-186, miR-328, miR-21, miR-29a Granulysin (GNLY), TGF-β, granzymes (Gzm-A & Gzm-B), perforin (PFN) Immunostimulatory [136,137]
Treg-derived exosomes
(Treg-exo)
CD25 and CTLA-4 miRNA-155, Let-7b, Let-7d IL-10, IL-35, and TGF-β Immunostimulatory [138,139]

BM, Bone Marrow; AD, Adipose Tissue; UC, Umbilical cord; PL, Placenta; DEX, Dendritic cell derived exosomes.